Not surprising.
Considering 20% of their first test subjects had serious adverse effects (which of course didn’t hit mainstream news), and then there was a press release about them going ahead with more trials on 10,000 people, would surely make logical sense to cash out before thousands of people get fucked. THAT is gonna be a bit more difficult to sugar-coat and keep out of headlines...
Yeah, bad to hope, but I hope it doesn't go well, and we find out about it...